机构:[1]The Center of Diagnosis and Treatment for Children's Bone Diseases, The Children’s Hospital Affiliated to Soochow University, Suzhou, China[2]Department of Orthopedics, The Affiliated Jiangyin Hospital of Medical College of Southeast University, Jiangyin City, China[3]Department of Orthopedics, The Second Affiliated Hospital of Soochow University, Suzhou, China[4]Department of Orthopedics, The First People’s Hospital of SuQian, SuQian, China
Forced-activation of AMP-activated protein kinase (AMPK) can possibly inhibit osteoblastoma cells. Here, we aim to provoke AMPK activation via microRNA silencing its phosphatase Ppm1e (protein phosphatase Mg2+/Mn2+-dependent 1e). We showed that microRNA-135b-5p("miR-135b-5p"), the anti-Ppm1e microRNA, was significantly downregulated in human osteoblastoma tissues. It was correlated with Ppm1e upregulation and AMPKa1 de-phosphorylation. Forced-expression of miR135b- 5p in human osteoblastoma cells (MG-63 and U2OS lines) silenced Ppm1e, and induced a profound AMPKa1 phosphorylation (at Thr-172). Osteoblastoma cell proliferation was inhibited after miR-135b-5p expression. Intriguingly, Ppm1e shRNA knockdown similarly induced AMPKa1 phosphorylation, causing osteoblastoma cell proliferation. Reversely, AMPKa1 shRNA knockdown or dominant negative mutation almost abolished miR-135b-5p's actions in osteoblastoma cells. Further in vivo studies demonstrated that U2OS tumor growth in mice was dramatically inhibited after expressing miR-135b-5p or Ppm1e shRNA. Together, our results suggest that miR-135b-induced Ppm1e silence induces AMPK activation to inhibit osteoblastoma cell proliferation.
基金:
The study was supported by the Nature Science Foundation of China. Grants from Natural Science Foundation of Jiangsu Province, and Young medical talents of Jiangsu Province (QNRC2016132).